Anti-CD19 chimeric antigen receptor T-cell therapy for relapsed or refractory Philadelphia chromosome-positive B cell acute lymphoblastic leukemia: a multicenter retrospective study. - Yu J; Song F; Zhang M; Zhao M; Sang W; Jiang S; Wang L; Wang X; Tu S; Li Y; Huang H; Hu Y; et al. (BMC medicine, 2026)